APE1 inhibitor (XPose Therapeutics)

N/A

Report date: 2025/03/14 18:10:47
NME

Base Information

Drug NameAPE1 inhibitor (XPose Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-(apurinic or apyrimidinic site) lyase inhibitors
TargetsDNA-(apurinic or apyrimidinic site) lyase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXpose Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesXpose Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A